Pacific Edge Set For Medicare Panel Review of Cxbladder Coverage

MT Newswires Live
Sep 15, 2025

Pacific Edge (ASX:PEB, NZE:PEB) received notification from Medicare Administrative Contractor (MAC) Novitas that an expert panel will be convened to review coverage for tests, including Cxbladder Triage, according to a Monday filing with the New Zealand and Australian bourses.

The review will focus on tests referenced in the 2025 update to the American Urological Association (AUA) microhematuria guideline, the filing said.

The contractor advisory committee, made up of urology experts, is set to convene in early 2026 to align Medicare policy with the 2025 AUA guideline update, per the filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10